Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | MTX@LNP-M13, methotrexate-loaded lipid nanoparticles-M13 |
| Catalog Number | R-C-00075 |
| Alias | Methotrexate Lipid Nanoparticles-M13 |
| Appearance | Milky white or light yellow semi-solid/liquid suspension |
| Molecular Formula | N/A |
| Solubility | Soluble in organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | Nanomedicine Research |
| Specification | 1mg:Inquiry 3mg:Inquiry 5mg: Inquiry |
| Description | MTX@LNP-M13 is an innovative drug delivery system formed by loading methotrexate (MTX) into lipid nanoparticles (LNP) and combined with M13 Bacteriophage related technology. M13 Bacteriophage is a filamentous Bacteriophage with high editability and targeting specificity. Incorporating its properties into LNP gives MTX@LNP-M13 unique advantages. This system can accurately identify specific antigens on the surface of tumor cells or diseased tissues, achieve targeted delivery of methotrexate, greatly improve the concentration of the drug in the lesion site, and enhance the treatment effect. At the same time, it effectively reduces the distribution of drugs in normal tissues and reduces side effects on other organs of the body. At present, MTX@LNP-M13 is mainly used in the field of tumor-targeted treatment and has shown good potential in cancer treatment research. However, it is still in the preclinical or early clinical research stage, and its large-scale application and long-term safety require further verification. |